These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Lipoprotein[a] is not present in the plasma of patients with some peroxisomal disorders. van der Hoek YY; Wanders RJ; van den Ende AE; Kraft HG; Gabel BR; Kastelein JJ; Koschinsky ML J Lipid Res; 1997 Aug; 38(8):1612-9. PubMed ID: 9300783 [TBL] [Abstract][Full Text] [Related]
28. Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Baumgartner MR; Poll-The BT; Verhoeven NM; Jakobs C; Espeel M; Roels F; Rabier D; Levade T; Rolland MO; Martinez M; Wanders RJ; Saudubray JM Ann Neurol; 1998 Nov; 44(5):720-30. PubMed ID: 9818927 [TBL] [Abstract][Full Text] [Related]
29. Peroxisome biogenesis disorders: genetics and cell biology. Gould SJ; Valle D Trends Genet; 2000 Aug; 16(8):340-5. PubMed ID: 10904262 [TBL] [Abstract][Full Text] [Related]
30. Genetic relationship between the Zellweger syndrome and other peroxisomal disorders characterized by an impairment in the assembly of peroxisomes. Tager JM; Brul S; Wiemer EA; Strijland A; Van Driel R; Schutgens RB; Van den Bosch H; Wanders RJ; Westerveld A Prog Clin Biol Res; 1990; 321():545-58. PubMed ID: 2183242 [TBL] [Abstract][Full Text] [Related]
31. Genetic diseases caused by peroxisomal dysfunction. New findings in clinical and biochemical studies. Schutgens RB; Wanders RJ; Nijenhuis A; van den Hoek CM; Heymans HS; Schrakamp G; Bleeker-Wagemakers EM; Delleman JW; Schram AW; Tager JM Enzyme; 1987; 38(1-4):161-76. PubMed ID: 3440444 [TBL] [Abstract][Full Text] [Related]
32. Peroxisomal disorders: clinical and biochemical studies in 15 children and prenatal diagnosis in 7 families. Steinberg SJ; Elçioglu N; Slade CM; Sankaralingam A; Dennis N; Mohammed SN; Fensom AH Am J Med Genet; 1999 Aug; 85(5):502-10. PubMed ID: 10405451 [TBL] [Abstract][Full Text] [Related]
33. Clinical and Biochemical Pitfalls in the Diagnosis of Peroxisomal Disorders. Klouwer FC; Huffnagel IC; Ferdinandusse S; Waterham HR; Wanders RJ; Engelen M; Poll-The BT Neuropediatrics; 2016 Aug; 47(4):205-20. PubMed ID: 27089543 [TBL] [Abstract][Full Text] [Related]
34. A common PEX1 frameshift mutation in patients with disorders of peroxisome biogenesis correlates with the severe Zellweger syndrome phenotype. Maxwell MA; Nelson PV; Chin SJ; Paton BC; Carey WF; Crane DI Hum Genet; 1999; 105(1-2):38-44. PubMed ID: 10480353 [TBL] [Abstract][Full Text] [Related]
35. Defective PEX gene products correlate with the protein import, biochemical abnormalities, and phenotypic heterogeneity in peroxisome biogenesis disorders. Shimozawa N; Imamura A; Zhang Z; Suzuki Y; Orii T; Tsukamoto T; Osumi T; Fujiki Y; Wanders RJ; Besley G; Kondo N J Med Genet; 1999 Oct; 36(10):779-81. PubMed ID: 10528859 [TBL] [Abstract][Full Text] [Related]
36. [Phenotype--genotype relationships in peroxisome biogenesis disorders]. Shimozawa N No To Shinkei; 2001 May; 53(5):411-20. PubMed ID: 11424351 [No Abstract] [Full Text] [Related]
37. Phenotypic variability (heterogeneity) of peroxisomal disorders. Mandel H; Korman SH Adv Exp Med Biol; 2003; 544():9-30. PubMed ID: 14713208 [TBL] [Abstract][Full Text] [Related]
38. Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders. Warren DS; Morrell JC; Moser HW; Valle D; Gould SJ Am J Hum Genet; 1998 Aug; 63(2):347-59. PubMed ID: 9683594 [TBL] [Abstract][Full Text] [Related]
39. Peroxisomal disorders: clinical commentary and future prospects. Wilson GN; Holmes RD; Hajra AK Am J Med Genet; 1988 Jul; 30(3):771-92. PubMed ID: 2461077 [TBL] [Abstract][Full Text] [Related]